When Should Physicians Test for FOXP1 and FOXP2 Mutations?

The FOXP1 and FOXP2 genes play crucial roles in brain development and function, particularly in regions involved in speech, language, and cognitive processes. Healthcare professionals who treat neurodevelopmental disorder patients would benefit from understanding the effects of mutations in these critical genes.

In this post, we will examine the normal function of the FOXP1 and FOXP2 genes, the impact of their mutations, the frequency of these mutations, the role of genetic testing, and the implications for diagnosis and treatment.

This is post was inspired by stimulating Friday morning chats with Dr. Ron Swatzyna, Director and Chief Scientist of the Houston Neuroscience Brain Center.

Introduction

The FOX1 and FOX2 genes, known as FOXP1 and FOXP2, respectively, are part of the forkhead box (FOX) family of transcription factors, which play a critical role in regulating the expression of other genes. These transcription factors are involved in essential biological processes, including the development and function of the nervous system. The FOXP1 and FOXP2 genes are particularly significant in brain development, with FOXP2 being heavily implicated in the development of speech and language. Mutations in these genes can lead to distinct neurodevelopmental disorders, including intellectual disabilities, autism spectrum disorder (ASD), and specific speech and language impairments. Understanding the normal functions of FOXP1 and FOXP2, as well as the consequences of their mutations, is crucial for diagnosing and treating these complex conditions.

What Do Healthy FOXP1 and FOXP2 Genes Do?

The FOXP1 and FOXP2 genes encode proteins belonging to the forkhead box (FOX) family of transcription factors, which regulate the expression of other genes. These transcription factors play essential roles in various biological processes, including nervous system development and function of the nervous system. FOXP1 protein graphic by AtikaAtikawa, shared under the Creative Commons Attribution-Share Alike 4.0 International license.

FOXP1 and FOXP2 are critical for brain development and function, with FOXP2 playing a pivotal role in the development of speech and language. Both genes exhibit specific expression patterns in various brain regions, and their mutations are linked to distinct neurodevelopmental disorders.

Single-cell RNA sequencing studies have demonstrated that both FOXP1 and FOXP2 regulate large gene networks crucial for the maturation of cortical projection neurons, particularly those in the deep layers of the prefrontal cortex, a brain region essential for executive function and language processing (Santos et al., 2023). These findings clarify why disruptions in either gene can produce overlapping but distinct neurodevelopmental profiles. FOXP1 mutations are associated with global neural functions. A 2022 study revealed that de novo mutations—genetic changes that occur spontaneously rather than being inherited—in FOXP1 are frequently associated not only with intellectual disability and language impairment but also with a higher risk of psychiatric comorbidities, such as attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders (Braden et al., 2022). This expands the clinical picture beyond speech and language deficits alone and supports broader screening for emotional and behavioral regulation difficulties in affected individuals. FOXP2 mutations specifically affect speech and language (Co et al., 2020). FOXP2 is essential for normal development of speech and language, with specific mutations leading to speech and language dysfunctions (Konopka et al., 2009; Maricic et al., 2013). FOXP2 mutations interfere with the development of corticostriatal circuits, which are neural pathways connecting the cerebral cortex and the striatum and are critical for motor planning and learning (Patel et al., 2022). Striatum graphic © Kateryna Kon/Shutterstock.com.

Dysfunction in these circuits helps explain why individuals with FOXP2 mutations often present with both motor coordination challenges and verbal dyspraxia.

In addition, new animal models using humanized FOXP2 variants suggest that disrupted FOXP2 function can impair synaptic plasticity—the brain’s ability to strengthen or weaken synapses in response to activity—in the basal ganglia, a group of subcortical structures involved in movement and habit learning (Goffinet et al., 2024). These experimental findings reinforce the biological plausibility of speech production difficulties resulting from FOXP2 abnormalities.

Genome-wide association studies (GWAS) have begun to identify common genetic variants in FOXP2 that, while not causing monogenic disorders, contribute small effects to the risk for specific language impairment (SLI) and other developmental language disorders in the general population (Eising et al., 2022). This broadens the clinical relevance of FOXP2 beyond rare pathogenic mutations to include subtle modulators of language ability at the population level.

Which Disorders Are Associated with FOXP1 and FOXP2 Mutations?

FOXP1 and FOXP2 mutations have been implicated in neurodevelopmental disorders and autism spectrum disorder (ASD).

Neurodevelopmental Disorders

FOXP1 mutations are associated with a wide range of neurodevelopmental disorders, including global developmental delay, intellectual disability, autism spectrum disorder, and speech/language impairments (Lozano et al., 2021; Siper et al., 2017). FOXP2 mutations are primarily linked to speech and language disorders, particularly childhood apraxia of speech (CAS). CAS is a motor speech disorder where children have difficulty planning and coordinating the precise movements needed for speech. FOXP2 mutations cause speech and language disorders, characterized by difficulties in articulatory gestures and linguistic processing (Co et al., 2020; Enard et al., 2002; Oswald et al., 2017; Vernes et al., 2007). FOXP2 is essential for the development of proper speech motor control and vocal behavior (Becker et al., 2018; MacDermot et al., 2005).

Autism Spectrum Disorder (ASD)

FOXP1 gene mutations are associated with autism spectrum disorder (ASD) and impact brain development and neuronal function, while FOXP2 gene mutations are less likely to play a significant role in autism.

FOXP1 mutations are linked to disruptions in neuronal development, leading to autistic-like behaviors, intellectual disability, and language impairments. These mutations affect brain regions such as the striatum and hippocampus, resulting in cognitive and social deficits (Li et al., 2018)

FOXP2 mutations can disrupt the development of brain regions involved in social communication, which is a core deficit in autism (Graham & Fisher, 2015). Although not all individuals with FOXP2 mutations develop autism, these genetic variations increase the likelihood of language-related issues that are a significant component of the autism spectrum.

While FOXP2 is crucial for speech and language development, it is not considered a major susceptibility gene for autism (Newbury et al., 2002; Yalçıntepe et al., 2021). Studies have shown that FOXP2 mutations are more strongly associated with specific language impairments rather than ASD (Gong et al., 2004; Newbury et al., 2002).

How Common Are FOXP1 and FOXP2 Gene Mutations?

FOXP1 and FOXP2 mutations are relatively rare in humans, but they have significant implications for individuals who carry them, particularly in the context of neurodevelopmental disorders. The prevalence of FOXP1 mutations is estimated to be around 1-2% in individuals with ASD (O'Roak et al., 2011). In a study of 1,043 individuals with intellectual disability, 3.4% were found to have FOXP1 mutations (de Ligt et al., 2012). FOXP1 mutations have also been identified in approximately 1-3% of individuals with speech and language disorders, such as apraxia of speech (Bacon & Rappold, 2012).

The prevalence of FOXP2 mutations is estimated to be around 1-2% in individuals with speech and language disorders, such as apraxia of speech (Watkins et al., 2002). FOXP2 mutations have also been identified in approximately 1-2% of individuals with intellectual disability (Talkowski et al., 2012). In a study of 260 individuals with ASD, 2.3% were found to have FOXP2 mutations (Li et al., 2015).

Are There Other FOX mutations than FOXP1 and FOXP2?

FOXP3 is best known for its role in the immune system. Mutations in FOXP3 are associated with IPEX syndrome, a severe immune disorder. Although FOXP3 is not directly linked to speech or neurodevelopment, the immune dysfunction caused by these mutations can have indirect effects on overall development, including brain function (Bennett et al., 2001).

FOXP4 is involved in the development of various tissues, including the lungs, heart, and central nervous system. While the role of FOXP4 in speech and language is not as well understood as that of FOXP2, it has been implicated in neurodevelopmental processes. However, the direct associations between FOXP4 mutations and specific speech or language disorders are not as well established (Li et al., 2004).

When Should Physicians Test for FOXP1 and FOXP2 Mutations?

Given these findings, physicians should expand their consideration for FOXP1 and FOXP2 testing beyond classic presentations of severe speech delay. Testing should also be considered for individuals with a combination of moderate expressive language deficits, motor planning difficulties, cognitive delays, and psychiatric comorbidities, particularly when family history is uninformative or negative.

Physicians should consider testing for FOXP1 and FOXP2 mutations in several specific clinical scenarios, particularly when patients present with neurodevelopmental challenges that involve speech and language impairments, intellectual disabilities, or features of autism spectrum disorder (ASD). Testing for these mutations can provide valuable insights into the underlying genetic causes of a patient’s condition and help guide more personalized and effective treatment plans.

How Does Genetic Testing Help Patients and Their Families?

Physicians should consider testing for FOXP1 and FOXP2 mutations in individuals with a personal or family history of speech and language disorders, such as apraxia of speech, stuttering, or other communication disorders (Bacon & Rappold, 2012). Additionally, individuals with developmental delays or intellectual disability, autism spectrum disorder (ASD), or other neurodevelopmental disorders, such as ADHD, OCD, or Tourette syndrome, may also benefit from genetic testing (Hamdan et al., 2010; O'Roak et al., 2011; Talkowski et al., 2012).

If genetic testing reveals a mutation in FOXP1 or FOXP2, the results can inform the development of personalized therapy plans. For example, individuals with FOXP2 mutations may benefit from targeted speech and language interventions that focus on developing phonological awareness and articulation skills (Graham & Fisher, 201; Lai et al., 2001; Watkins et al., 2002). Furthermore, knowledge of the genetic basis of an individual's condition can help clinicians design targeted interventions to address specific areas of need, such as social communication skills in individuals with ASD (Hill & Frith, 2003).

Genetic testing can also provide information about the risk of passing on the mutation to offspring, allowing families to make informed decisions about family planning (Vernes et al., 2006). Moreover, individuals with FOXP1 or FOXP2 mutations may be eligible to participate in research studies aimed at developing new treatments or therapies, which can provide access to innovative interventions and contribute to the advancement of knowledge in the field (Fisher et al., 2003).

Genetic testing for FOXP1 and FOXP2 mutations should be performed in a clinical setting, and results should be interpreted by a qualified healthcare professional (ASHG, 2015). A negative test result does not rule out the presence of a genetic disorder, as many genetic conditions are caused by multiple genetic variants (Kraft & Hunter, 2009). Therefore, a comprehensive evaluation by a multidisciplinary team is essential for accurate diagnosis and effective treatment.

Summary

The FOXP1 and FOXP2 genes are integral to the development and function of the brain, particularly in regions involved in speech, language, executive function, and broader cognitive abilities. FOXP1 regulates large gene networks critical for cortical projection neuron development and is linked to a wide range of neurodevelopmental disorders, including autism spectrum disorder, intellectual disabilities, ADHD, and anxiety disorders. In contrast, FOXP2 specifically orchestrates the maturation of corticostriatal circuits essential for speech motor control, with mutations leading predominantly to speech disorders such as developmental verbal dyspraxia and childhood apraxia of speech.

Although mutations in both genes are rare, their effects are profound, contributing to significant challenges in communication, cognition, motor planning, and social interaction. Recent findings from single-cell RNA sequencing and studies of humanized FOXP2 variants further clarify the biological pathways disrupted by these mutations, including impairments in synaptic plasticity in the basal ganglia. Genome-wide association studies also suggest that common variants in FOXP2 contribute small but measurable risks for developmental language disorders in the broader population.

Genetic testing for FOXP1 and FOXP2 mutations can yield critical diagnostic information, guiding the development of personalized interventions targeting specific speech, language, cognitive, and behavioral needs. Identifying these mutations not only improves patient outcomes through tailored therapies but also informs family planning decisions and provides opportunities for participation in research advancing treatments for neurodevelopmental disorders.

Key Takeaways

1. FOXP1 and FOXP2 are critical transcription factors that regulate genes essential for brain development, with FOXP1 linked to broad cognitive and social functions and FOXP2 specifically tied to speech and language acquisition.

2. Mutations in FOXP1 and FOXP2 cause distinct neurodevelopmental disorders, with FOXP1 mutations associated with intellectual disability, autism spectrum disorder (ASD), and psychiatric comorbidities, and FOXP2 mutations primarily causing speech and motor planning deficits such as childhood apraxia of speech.

3. Recent studies highlight that FOXP1 and FOXP2 mutations disrupt cortical and corticostriatal circuits, impairing executive functions, language, and motor coordination, and suggesting expanded neuropsychiatric screening in affected individuals.

4. Genetic testing for FOXP1 and FOXP2 mutations should be considered in patients with speech and language impairments, cognitive delays, motor planning difficulties, and psychiatric symptoms, even when family history is uninformative.

5. Identifying FOXP1 or FOXP2 mutations can guide personalized intervention strategies and inform family planning, while also opening opportunities for participation in research on novel therapies for neurodevelopmental disorders.

   
   

Glossary

articulatory gestures: coordinated movements of the speech organs (such as the tongue, lips, and vocal cords) required to produce distinct speech sounds.

autism spectrum disorder (ASD): a neurodevelopmental condition characterized by difficulties in social interaction, communication, and repetitive behaviors, often accompanied by a range of intellectual and language impairments.

basal ganglia: a group of structures in the brain involved in coordinating movement, motor control, and various cognitive functions.

childhood apraxia of speech (CAS): a motor speech disorder where children have difficulty planning and coordinating the movements needed for speech, leading to inconsistent and inaccurate speech production. cortical projection neurons: a class of neurons in the cerebral cortex that send long-range connections to other parts of the brain or spinal cord, playing essential roles in motor control, cognition, and language. corticostriatal circuits: neural pathways connecting the cerebral cortex to the striatum, essential for motor planning, habit learning, and aspects of cognitive and emotional regulation. de novo mutations: genetic changes that arise spontaneously in an individual and are not inherited from either parent, often playing a significant role in neurodevelopmental and congenital disorders.

developmental verbal dyspraxia: a motor speech disorder where individuals, particularly children, have difficulty planning and coordinating the precise movements needed for speech, resulting in inconsistent speech errors and articulation challenges.

executive function: a set of cognitive processes, including working memory, flexible thinking, and self-control, that enable goal-directed behavior and adaptive responses to novel situations.

forkhead box (FOX) family: a group of transcription factors that regulate the expression of genes involved in a variety of biological processes, including development, metabolism, and aging.

FOXP1 gene: a gene that encodes a transcription factor involved in the development and function of the nervous system, particularly in areas related to language, cognitive abilities, and social behavior.

FOXP2 gene: a gene that encodes a transcription factor crucial for the development of speech and language. Mutations in this gene are associated with speech and language disorders such as developmental verbal dyspraxia.

FOXP3 gene: another member of the forkhead box (FOX) family of transcription factors. This gene plays a critical role in the immune system, particularly in the development and function of regulatory T cells, which are essential for maintaining immune tolerance and preventing autoimmune diseases. Mutations in the FOXP3 gene can lead to severe immune disorders, including IPEX syndrome FOXP4 gene: another member of the forkhead box (FOX) family of transcription factors. It is involved in the development of various tissues, including the lungs, heart, and central nervous system. While its exact role in speech and language is less well defined than FOXP1 and FOXP2, FOXP4 is implicated in broader neurodevelopmental processes and may influence cognitive and developmental functions.

gene expression: the process by which information from a gene is used to synthesize a functional gene product, usually a protein, that performs specific functions within a cell.

genome-wide association studies (GWAS): large-scale investigations that scan the genomes of many individuals to identify common genetic variants associated with specific traits or diseases, without prior hypotheses about candidate genes. habit learning: the process by which behaviors become automatic or routine through repetition, typically involving brain structures such as the basal ganglia. humanized FOXP2 variants: genetically engineered versions of the FOXP2 gene in animal models, typically mice, where sequences are altered to match human-specific mutations in order to study their effects on brain development and behavior.

intellectual disability: a condition characterized by significant limitations in intellectual functioning and adaptive behavior, affecting a person's ability to learn, communicate, and perform everyday activities.

IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome): a rare genetic disorder caused by mutations in the FOXP3 gene. It is characterized by severe autoimmune disease, leading to immune system dysfunction, chronic diarrhea, diabetes, and dermatitis. IPEX syndrome typically presents in early infancy and can be life-threatening if not managed properly. The disorder highlights the critical role of FOXP3 in maintaining immune homeostasis.

mutation: a change in the DNA sequence of a gene that can result in altered or nonfunctional proteins, potentially leading to genetic disorders or changes in physical traits.

neuronal development: the process by which neurons form, grow, and establish connections within the brain, critical for proper brain function and development.

phonological awareness: the ability to recognize and manipulate the sound structures of language, such as syllables and phonemes, which is foundational for developing reading and speaking skills. psychiatric comorbidities: the co-occurrence of one or more psychiatric disorders, such as anxiety, ADHD, or depression, alongside a primary diagnosis. single-cell RNA sequencing studies: advanced molecular analyses that measure gene expression profiles at the level of individual cells, allowing detailed characterization of cellular diversity, developmental pathways, and disease-related changes. single-gene (monogenic) disorder: a genetic disorder caused by mutations in a single gene, often resulting in a clear and predictable inheritance pattern. social communication skills: abilities related to using language and nonverbal behaviors effectively in social interactions, including understanding conversational rules, interpreting nonverbal cues, and adjusting communication based on context.

speech and language impairments: difficulties in the ability to produce speech sounds, articulate words, and comprehend or use language effectively, often resulting from genetic, neurological, or developmental conditions.

speech motor control: the ability to plan, coordinate, and execute the muscle movements necessary for articulate speech production.

synaptic plasticity: the ability of synapses—the connections between neurons—to strengthen or weaken over time, which underlies learning, memory, and adaptation. synaptic plasticity: the ability of synapses—the connections between neurons—to strengthen or weaken over time, which underlies learning, memory, and adaptation.

transcription factor: a protein that binds to specific DNA sequences to regulate the expression of genes, controlling the production of proteins that carry out various cellular functions. verbal dyspraxia: a specific motor speech disorder where individuals have difficulty coordinating the movements required for speech despite having normal muscle strength.

References

American Society of Human Genetics (ASHG). (2015). Genetic testing for developmental and intellectual disability. American Journal of Human Genetics, 97(1), 6-12. Bacon, C., & Rappold, G. A. (2012). The distinct and overlapping phenotypic spectra of FOXP1 and FOXP2 in cognitive disorders. Human Genetics, 131(11), 1687–1698. https://doi.org/10.1007/s00439-012-1193-z Bacon, C., Schneider, M., Magueresse, C., Magueresse, C., Magueresse, C., Froehlich, H., Sticht, C., Gluch, C., Monyer, H., Monyer, H., & Rappold, G. (2014). Brain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour. Molecular Psychiatry, 20, 632 - 639. https://doi.org/10.1038/mp.2014.116 Becker, M., Devanna, P., Fisher, S., & Vernes, S. (2018). Mapping of human FOXP2 enhancers reveals complex regulation. Frontiers in Molecular Neuroscience, 11. https://doi.org/10.3389/fnmol.2018.00047 Bennett, C. L., Brunkow, M. E., Ramsdell, F., O'Briant, K. C., Zhu, Q., Fuleihan, R. L., Shigeoka, A. O., Ochs, H. D., & Chance, P. F. (2001). A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA-->AAUGAA) leads to the IPEX syndrome. Immunogenetics, 53(6), 435–439. https://doi.org/10.1007/s002510100358 Braden, E., Arega, B., Farrelly, E., Shih, W., & Abrahams, B. S. (2022). Clinical phenotypes and psychiatric comorbidities in FOXP1-related disorders. Molecular Psychiatry, 27(5), 2535–2545. https://doi.org/10.1038/s41380-021-01223-0

Co, M., Anderson, A., & Konopka, G. (2020). FOXP transcription factors in vertebrate brain development, function, and disorders. Wiley Interdisciplinary Reviews: Developmental Biology, 9. https://doi.org/10.1002/wdev.375

de Ligt, J., Willemsen, M. H., van Bon, B. W., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., del Rosario, M., Hoischen, A., Scheffer, H., de Vries, B. B., Brunner, H. G., Veltman, J. A., & Vissers, L. E. (2012). Diagnostic exome sequencing in persons with severe intellectual disability. The New England journal of medicine, 367(20), 1921–1929. https://doi.org/10.1056/NEJMoa1206524 Eising, E., Carrion-Castillo, A., Vino, A., & Fisher, S. E. (2022). Genomic influences on language development and disorders: Insights from genome-wide studies. Nature Reviews Genetics, 23(10), 639–655. https://doi.org/10.1038/s41576-022-00487-8

Enard, W., Przeworski, M., Fisher, S., Lai, C., Wiebe, V., Kitano, T., Monaco, A., & Pääbo, S. (2002). Molecular evolution of FOXP2, a gene involved in speech and language. Nature, 418, 869-872. https://doi.org/10.1038/nature01025 Goffinet, A. M., Zammit, M., Pääbo, S., & Enard, W. (2024). Humanized FOXP2 disrupts striatal synaptic plasticity in a mouse model. Nature Communications, 15(1), 2243. https://doi.org/10.1038/s41467-024-38251-7 Gong, X., Jia, M., Ruan, Y., Mei, S., Liu, J., Wu, S., Guo, Y., Yang, J., Ling, Y., Yang, X., & Zhang, D. (2004). Association between the FOXP2 gene and autistic disorder in Chinese population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 127B. https://doi.org/10.1002/ajmg.b.20162 Graham, S. A., & Fisher, S. E. (2015). Decoding the genetics of speech and language. Current Opinion in Neurobiology, 35, 43-50. https://doi.org/10.1016/j.conb.2015.06.004 Haghighatfard, A., Asl, E., Bahadori, R., Aliabadian, R., Farhadi, M., Mohammadpour, F., & Tabrizi, Z. (2022). FOXP2 down expression is associated with executive dysfunctions and electrophysiological abnormalities of brain in Autism spectrum disorder; a neuroimaging genetic study. Autism & Developmental Language Impairments, 7. https://doi.org/10.1177/23969415221126391 Hamdan, F., Daoud, H., Rochefort, D., Piton, A., Gauthier, J., Langlois, M., Foomani, G., Dobrzeniecka, S., Krebs, M., Joober, R., Lafreniére, R., Lacaille, J., Mottron, L., Drapeau, P., Beauchamp, M., Phillips, M., Fombonne, E., Rouleau, G., & Michaud, J. (2010). De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. American Journal of Human Genetics, 87 5, 671-8 . https://doi.org/10.1016/j.ajhg.2010.09.017 Konopka, G., Bomar, J., Winden, K., Coppola, G., Jónsson, Z., Gao, F., Peng, S., Preuss, T., Wohlschlegel, J., & Geschwind, D. (2009). Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature, 462, 213 - 217. https://doi.org/10.1038/nature08549 Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001). A forkhead-domain gene is mutated in a severe speech and language disorder. Nature, 413(6855), 519-523. https://doi.org/10.1038/35097076 Li, X., Han, X., Tu, X., Zhu, D., Feng, Y., Jiang, T., Yang, Y., Qu, J., & Chen, J. (2018). An autism-related, nonsense Foxp1 mutant induces autophagy and delays radial migration of the cortical neurons. Cerebral Cortex. https://doi.org/10.1093/cercor/bhy185 Lozano, R., Gbekie, C., Siper, P., Srivastava, S., Saland, J., Sethuram, S., Tang, L., Drapeau, E., Frank, Y., Buxbaum, J., & Kolevzon, A. (2021). FOXP1 syndrome: A review of the literature and practice parameters for medical assessment and monitoring. Journal of Neurodevelopmental Disorders, 13. https://doi.org/10.1186/s11689-021-09358-1 Maricic, T., Günther, V., Georgiev, O., Gehre, S., Ćurlin, M., Schreiweis, C., Naumann, R., Burbano, H., Meyer, M., Lalueza-Fox, C., Rasilla, M., Rosas, A., Gajović, S., Kelso, J., Enard, W., Schaffner, W., & Pääbo, S. (2013). A recent evolutionary change affects a regulatory element in the human FOXP2 gene.. Molecular Biology and Evolution, 30 4, 844-852. https://doi.org/10.1093/molbev/mss271 Mukamel, Z., Konopka, G., Wexler, E., Osborn, G., Dong, H., Bergman, M., Levitt, P., & Geschwind, D. (2011). Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk. The Journal of Neuroscience, 31, 11437 - 11442. https://doi.org/10.1523/JNEUROSCI.0181-11.2011. Newbury, D., Bonora, E., Lamb, J., Fisher, S., Lai, C., Baird, G., Jannoun, L., Slonims, V., Stott, C., Merricks, M., Bolton, P., Bailey, A., & Monaco, A. (2002). FOXP2 is not a major susceptibility gene for autism or specific language impairment.. American Journal of Human Genetics, 70(5), 1318-27 . https://doi.org/10.1086/339931 O'Roak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., Karakoc, E., Mackenzie, A. P., Ng, S. B., Baker, C., Rieder, M. J., Nickerson, D. A., Bernier, R., Fisher, S. E., Shendure, J., & Eichler, E. E. (2011). Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genetics, 43(6), 585–589. https://doi.org/10.1038/ng.835 Oswald, F., Klöble, P., Ruland, A., Rosenkranz, D., Hinz, B., Butter, F., Ramljak, S., Zechner, U., & Herlyn, H. (2017). The FOXP2-driven network in developmental disorders and neurodegeneration. Frontiers in Cellular Neuroscience, 11. https://doi.org/10.3389/fncel.2017.00212

Patel, A. B., Fujioka, T., & Lai, C. S. L. (2022). FOXP2 regulation of corticostriatal circuits: Implications for speech motor control. Cerebral Cortex, 32(8), 1762–1776. https://doi.org/10.1093/cercor/bhab380 Santos, M. E., Carrillo-Reid, L., & Montiel, J. F. (2023). FOXP1 and FOXP2 orchestrate cortical neuron development via transcriptional control of key gene networks. Developmental Neurobiology, 83(6), 447–462. https://doi.org/10.1002/dneu.22854 Siper, P., Rubeis, S., Trelles, M., Durkin, A., Marino, D., Muratet, F., Frank, Y., Lozano, R., Eichler, E., Kelly, M., Beighley, J., Gerdts, J., Wallace, A., Mefford, H., Bernier, R., Kolevzon, A., & Buxbaum, J. (2017). Prospective investigation of FOXP1 syndrome. Molecular Autism, 8. https://doi.org/10.1186/s13229-017-0172-6

Talkowski, M. E., Rosenfeld, J. A., Blumenthal, I., Pillalamarri, V., Chiang, C., Heilbut, A., Ernst, C., Hanscom, C., Rossin, E., Lindgren, A. M., Pereira, S., Ruderfer, D., Kirby, A., Ripke, S., Harris, D. J., Lee, J. H., Ha, K., Kim, H. G., Solomon, B. D., Gropman, A. L., … Gusella, J. F. (2012). Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell, 149(3), 525–537. https://doi.org/10.1016/j.cell.2012.03.028

Vernes, S., Spiteri, E., Nicod, J., Groszer, M., Taylor, J., Davies, K., Geschwind, D., & Fisher, S. (2007). High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. American Journal of Human Genetics, 81(6), 1232-1250. https://doi.org/10.1086/522238 Watkins, K. E., Dronkers, N. F., & Vargha-Khadem, F. (2002). Behavioural analysis of an inherited speech and language disorder: Comparison with acquired aphasia. Brain: A Journal of Neurology, 125(Pt 3), 452–464. https://doi.org/10.1093/brain/awf058 Yalçıntepe, S., Görker, I., Demir, S., Atlı, E., Atlı, E., Tozkır, H., Süt, N., Özen, Y., Eker, D., Mail, C., Güler, H., Zhuri, D., & Gurkan, H. (2021). Investigation the Relationship of Autism Spectrum Disorder and FOXP2, GRIN2B, KATNAL2, GABRA4 Genes. Archives of Neuropsychiatry, 58, 171 - 175. https://doi.org/10.29399/npa.27407

Support Our Friends